Aav capsid variants and uses thereof
AssigneeVoyager Therapeutics, Inc.
InventorsMathieu Emmanuel Nonnenmacher, Jing Lin, Hongxing Wang, Jinzhao Hou, Wei Wang, Jiangyu Li
Life of this patent
Estimating the term…
Abstract
The disclosure relates to compositions and methods for the preparation, use, and/or formulation of adeno-associated virus capsid protein variants.
Claims36
An adeno-associated virus (AAV) capsid variant, comprising an amino acid sequence having the following formula:
- [N1]-[N2]-[N3] (SEQ ID NO:
- 4681), wherein [N2] comprises the amino acid sequence of DWHR (SEQ ID NO:
- 4682) and wherein:
- (i) [N1] comprises positions X1, X2, X3, and X4, wherein position X4 is Q, K, E, S, P, R, N, or H;
- and/or
- (ii) [N3] comprises positions X5, X6, and X7, wherein position X5 is I, V, T, M, S, N, L, or F;
- wherein the AAV capsid variant comprises the amino acid sequence of positions 203-736 of SEQ ID NO:
- 981, or an amino acid sequence at least 95% identical to positions 203-736 of SEQ ID NO:
- 981.
(canceled)
-13. (canceled)
(canceled)
An adeno-associated virus (AAV) capsid variant comprising:
- (a) the amino acid sequence of any of the sequences provided in Tables 1, 2A, 2B, 9, 14, 15 or 16;
- (b) an amino acid sequence comprising at least 7, 8, 9, 10, 11, 12, 13, or 14 consecutive amino acids from any one of the sequences provided in Tables 1, 2A, 2B, 9, 14, 15, or 16;
- (c) an amino acid sequence comprising at least one, two, or three but no more than four different amino acids, relative to any one of the sequences provided in Tables 1, 2A, 2B, 9, 14, 15, or 16;
- or
- (d) an amino acid sequence comprising at least one, two, or three but no more than four substitutions, relative to the amino acid sequence of any one of the sequences provided in Tables 1, 2A, 2B, 9, 14, 15, or 16;
- wherein the AAV capsid variant comprises the amino acid sequence of positions 203-736 of SEQ ID NO:
- 981, or an amino acid sequence at least 95% identical to positions 203-736 of SEQ ID NO:
- 981.
(canceled)
An adeno-associated virus (AAV) capsid variant comprising an amino acid sequence at least 95% identical to positions 203-736 of SEQ ID NO:
- 981, wherein the AAV capsid variant comprises the amino acid T at position 584, the amino acid D at position 586, the amino acid W at position 587, the amino acid H at position 588, the amino acid R at position 589, and the amino acid I at position 590, numbered according to SEQ ID NO:
- 981.
-22. (canceled)
-26. (canceled)
(canceled)
A peptide comprising:
- (a) the amino acid sequence of any of the sequences provided in Tables 1, 2A, 2B, 14, 15, or 16;
- (b) an amino acid sequence comprising at least 7, 8, 9, 10, 11, 12, 13, or 14 consecutive amino acids from any one of the sequences provided in Tables 1, 2A, 2B, 14, 15, or 16;
- (c) an amino acid sequence comprising at least one, two, or three but no more than four different amino acids relative to the amino acid sequence of any one of the sequences provided in Tables 1, 2A, 2B, 14, 15, or 16;
- or
- (d) an amino acid sequence comprising at least one, two, or three but no more than four substitutions, relative to the amino acid sequence of any one of the sequences provided in Tables 1, 2A, 2B, 14, 15, or 16.
-32. (canceled)
(canceled)
-37. (canceled)
-42. (canceled)
(canceled)
-61. (canceled)
Dependencies are inferred from the claim text.